0.58
-0.024(-3.98%)
Currency In USD
| Previous Close | 0.6 |
| Open | 0.62 |
| Day High | 0.62 |
| Day Low | 0.53 |
| 52-Week High | 17.8 |
| 52-Week Low | 0.53 |
| Volume | 170,292 |
| Average Volume | 76,665 |
| Market Cap | 1.25M |
| PE | -0.04 |
| EPS | -13.81 |
| Moving Average 50 Days | 1.36 |
| Moving Average 200 Days | 3.87 |
| Change | -0.02 |
If you invested $1000 in HCW Biologics Inc. (HCWB) since IPO date, it would be worth $91.9 as of February 21, 2026 at a share price of $0.579. Whereas If you bought $1000 worth of HCW Biologics Inc. (HCWB) shares 3 years ago, it would be worth $7.82 as of February 21, 2026 at a share price of $0.579.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
GlobeNewswire Inc.
Feb 18, 2026 2:50 AM GMT
MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend health span by tar
HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune
GlobeNewswire Inc.
Feb 13, 2026 1:30 PM GMT
HCW Biologics receiving cash fee and co-founder shares in Trimmunevalued at $7.0 million Trimmune will hold exclusive worldwide license for rights to high potential preclinical molecule created with HCW Biologics’ TRBC drug development platform Initi
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Nov 19, 2025 1:30 PM GMT
MIRAMAR, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend health sp